The function of donor versus recipient programmed death-ligand 1 in corneal allograft survival

Journal of Immunology

Volumn 179, Issue 6, 2007, Pages 3672-3679

  Shen, Linling ^a   Jin, Yiping ^a   Freeman, Gordon J ^b   Sharpe, Arlene H ^c   Dana, M Reza ^a,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD11B ANTIGEN; CD45 ANTIGEN; CELL SURFACE PROTEIN; MONOCLONAL ANTIBODY; PROGRAMMED DEATH LIGAND 1; PROGRAMMED DEATH LIGAND 2; UNCLASSIFIED DRUG; MEMBRANE PROTEIN; PDCD1LG1 PROTEIN, MOUSE; PEPTIDE;

ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CELL INFILTRATION; CONTROLLED STUDY; CORNEA EPITHELIUM; CORNEA TRANSPLANTATION; EPITHELIUM CELL; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNE RESPONSE; IMMUNOREGULATION; KERATITIS; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; ORGAN DONOR; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL MOTION; COMPARATIVE STUDY; CORNEA; DONOR; DOWN REGULATION; DRUG ANTAGONISM; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; T LYMPHOCYTE SUBPOPULATION; TRANSPLANTATION;

ANIMALS; ANTIGENS, CD45; ANTIGENS, CD80; CELL MOVEMENT; CORNEA; CORNEAL TRANSPLANTATION; DOWN-REGULATION; GRAFT ENHANCEMENT, IMMUNOLOGIC; GRAFT SURVIVAL; IMMUNE TOLERANCE; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; PEPTIDES; T-LYMPHOCYTE SUBSETS; TISSUE DONORS;

EID: 35748972357     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.6.3672     Document Type: Article

References (31)

1. Dong, H., G. Zhu, K. Tamada, and L. Chen. 1999. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat. Med. 5: 1365-1369.
2. Freeman, G. J., A. J. Long, Y. Iwai, K. Bourque, T. Chernova, H. Nishimura, L. J. Fitz, N. Malenkovich, T. Okazaki, M. C. Byrne, et al. 2000. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192: 1027-1034.
3. Tseng, S. Y., M. Otsuji, K. Gorski, X. Huang, J. E. Slansky, S. I. Pai, A. Shalabi, T. Shin, D. M. Pardoll, and H. Tsuchiya. 2001. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J. Exp. Med. 193: 839-846.
4. Latchman, Y., C. R. Wood, T. Chernova, D. Chaudhary, M. Borde, I. Chernova, Y. Iwai, A. J. Long, J. A. Brown, R. Nunes, et al. 2001. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2: 261-268.
5. Yamazaki, T., H. Akiba, H. Iwai, H. Matsuda, M. Aoki, Y. Tanno, T. Shin, H. Tsuchiya, D. M. Pardoll, K. Okumura, et al. 2002. Expression of programmed death 1 ligands by murine T cells and APC. J. Immunol. 169: 5538-5545.
6. Mazanet, M. M., and C. C. Hughes. 2002. B7-H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis. J. Immunol. 169: 3581-3588.
7. Eppihimer, M. J., J. Gunn, G. J. Freeman, E. A. Greenfield, T. Chernova, J. Erickson, and J. P. Leonard. 2002. Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells. Microcirculation 9: 133-145.
8. Brown, J. A., D. M. Dorfman, F. R. Ma, E. L. Sullivan, O. Munoz, C. R. Wood, E. A. Greenfield, and G. J. Freeman. 2003. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J. Immunol. 170: 1257-1266.
9. + T cell activation and cytolysis. Eur. J. Immunol. 33: 3117-3126.
10. Subudhi, S. K., P. Zhou, L. M. Yerian, R. K. Chin, J. C. Lo, R. A. Anders, Y. Sun, L. Chen, Y. Wang, M. L. Alegre, and Y. X. Fu. 2004. Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection. J. Clin. Invest. 113: 694-700.
11. Ansari, M. J., A. D. Salama, T. Chitnis, R. N. Smith, H. Yagita, H. Akiba, T. Yamazaki, M. Azuma, H. Iwai, S. J. Khoury, et al. 2003. The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med. 198: 63-69.
12. Latchman, Y. E., S. C. Liang, Y. Wu, T. Chernova, R. A. Sobel, M. Klemm, V. K. Kuchroo, G. J. Freeman, and A. H. Sharpe. 2004. PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells. Proc. Natl. Acad. Sci. USA 101: 10691-10696.
13. Carter, L. L., M. W. Leach, M. L. Azoitei, J. Cui, J. W. Pelker, J. Jussif, S. Benoit, G. Ireland, D. Luxenberg, G. R. Askew, et al. 2007. PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 182: 124-134.
14. Keir, M. E., S. C. Liang, I. Guleria, Y. E. Latchman, A. Qipo, L. A. Albacker, M. Koulmanda, G. J. Freeman, M. H. Sayegh, and A. H. Sharpe. 2006. Tissue expression of PD-L1 mediates peripheral T cell tolerance. J. Exp. Med. 203: 883-895.
15. Ozkaynak, E., L. Wang, A. Goodearl, K. McDonald, S. Qin, T. O'Keefe, T. Duong, T. Smith, J. C. Gutierrez-Ramos, J. B. Rottman, et al. 2002. Programmed death-1 targeting can promote allograft survival. J. Immunol. 169: 6546-6553.
16. Gao, W., G. Demirci, T. B. Strom, and X. C. Li. 2003. Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival. Transplantation 76: 994-999.
17. Watson, M. P., A. J. George, and D. F. Larkin. 2006. Differential effects of costimulatory pathway modulation on corneal allograft survival. Invest. Ophthalmol. Visual Sci. 47: 3417-3422.
18. Niederkorn, J. Y. 2003. The immune privilege of corneal grafts. J. Leukocyte Biol. 74: 167-171.
19. + T cells in immunobiology of orthotopic corneal transplants in mice. Invest. Ophthalmol. Visual Sci. 40: 2614-2621.
20. + T cells in allorecognition: lessons from corneal transplantation. J. Immunol. 167: 1891-1899.
21. Sano, Y., J. W. Streilein, and B. R. Ksander. 1999. Detection of minor alloantigen-specific cytotoxic T cells after rejection of murine orthotopic corneal allografts: evidence that graft antigens are recognized exclusively via the "indirect pathway." Transplantation 68: 963-970.
22. Joo, C. K., J. S. Pepose, and P. M. Stuart. 1995. T-cell mediated responses in a murine model of orthotopic corneal transplantation. Invest. Ophthalmol. Visual Sci. 36: 1530-1540.
23. Yamada, J., B. R. Ksander, and J. W. Streilein. 2001. Cytotoxic T cells play no essential role in acute rejection of orthotopic corneal allografts in mice. Invest. Ophthalmol. Visual Sci. 42: 386-392.
24. Yamada, J., and J. W. Streilein. 1998. Fate of orthotopic corneal allografts in C57BL/6 mice. Transplant Immunol. 6: 161-168.
25. Hamrah, P., Q. Zhang, Y. Liu, and M. R. Dana. 2002. Novel characterization of MHC class II-negative population of resident corneal Langerhans cell-type dendritic cells. Invest. Ophthalmol. Visual Sci. 43: 639-646.
26. Seo, S. K., H. Y. Park, J. H. Choi, W. Y. Kim, Y. H. Kim, H. W. Jung, B. Kwon, H. W. Lee, and B. S. Kwon. 2003. Blocking 4-1BB/4-1BB ligand interactions prevents herpetic stromal keratitis. J. Immunol. 171: 576-583.
27. Benichou, G., A. Valujskikh, and P. S. Heeger. 1999. Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice. J. Immunol. 162: 352.
28. Hamrah, P., S. O. Huq, Y. Liu, Q. Zhang, and M. R. Dana. 2003. Corneal immunity is mediated by heterogeneous population of antigen-presenting cells. J. Leukocyte Biol. 74: 172-178.
29. Huq, S., Y. Liu, G. Benichou, and M. R. Dana. 2004. Relevance of the direct pathway of sensitization in corneal transplantation is dictated by the graft bed microenvironment. J. Immunol. 173: 4464-4469.
30. Hori, J., M. Wang, M. Miyashita, K. Tanemoto, H. Takahashi, T. Takemori, K. Okumura, H. Yagita, and M. Azuma. 2006. B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts. J. Immunol. 177: 5928-5935.
31. Youngnak-Piboonratanakit, P., F. Tsushima, N. Otsuki, H. Igarashi, U. Machida, H. Iwai, Y. Takahashi, K. Omura, H. Yokozeki, and M. Azuma. 2003. Keratinocytes induce local tolerance to skin graft by activating interleukin-10-secreting T cells in the context of costimulation molecule B7-H1. Transplantation 75: 1390-1396.